Takeda Pharmaceutical Company Limited Impairment Loss
Takeda Pharmaceutical Company Limited (TKPHF) reported Impairment Loss of JPY 106.53 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLoss · last filed 2025-06-25
| Period end | Impairment Loss 12 month |
|---|---|
| 2025-03-31 | 106.53B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 150.02B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 64.39B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 54.52B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 25.45B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 101.88B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 10.12B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 13.54B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 51.36B JPY 20-F · filed 2019-06-27 |